Douglas V. Faller - Feb 18, 2025 Form 4 Insider Report for Imunon, Inc. (IMNN)

Role
Chief Medical Officer
Signature
/s/ Susan Eylward, Attorney-in-Fact for Douglas V. Faller
Stock symbol
IMNN
Transactions as of
Feb 18, 2025
Transactions value $
$0
Form type
4
Date filed
2/19/2025, 04:17 PM
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMNN Stock Option (Right to Buy) Award $0 +100K $0.00 100K Feb 18, 2025 Common Stock 100K $0.86 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the closing price of Imunon, Inc. Common Stock on the date of the grant
F2 The options shall vest and become exercisable as to 1/4 on the one year anniversary of the grant date and each remaining 1/4 on the second, third and fourth year anniversary of the grant date, subject to the grantee's continued service as an employee through each applicable vesting date.